Chapter
Higher Rates of Psychotropic Drug Prescriptions among Foster Children
Higher Rates of Potential Health Risk Indicators among Foster Children
SELECTED STATES’ PSYCHOTROPIC DRUG MONITORING PROGRAMS FALL SHORT OF AACAP- BEST PRINCIPLES GUIDELINES
RECOMMENDATION FOR EXECUTIVE ACTION
AGENCY COMMENTS AND OUR EVALUATION
APPENDIX I. OBJECTIVES, SCOPE, AND METHODOLOGY
APPENDIX II. USES AND SIDE EFFECTS OF PSYCHOTROPIC DRUGS52
APPENDIX III. LIST OF PSYCHOTROPIC DRUGS USED IN ANALYSIS
APPENDIX IV. RATES OF PSYCHOTROPIC PRESCRIPTION USAGE BY LENGTH OF TIME IN MEDICAID FEE-FOR-SERVICE
APPENDIX V. ADDITIONAL DATA ON CHILDREN WITH PRESCRIPTIONS OF AT LEAST ONE PSYCHOTROPIC DRUG
APPENDIX VI. ADDITIONAL DATA ON CONCOMITANT PRESCRIPTIONS
APPENDIX VII. ADDITIONAL DATA ON PSYCHOTROPIC DRUG PRESCRIPTIONS EXCEEDING MAXIMUM RECOMMENDED DOSES
APPENDIX VIII. ADDITIONAL DATA ON PSYCHOTROPIC PRESCRIPTIONS TO CHILDREN UNDER 1 YEAR OLD
APPENDIX IX. ADDITIONAL DATA ON PSYCHOTROPIC DRUGS WITH GAPS IN PRESCRIPTIONS OF 7 TO 29 DAYS
APPENDIX X. SELECTED STATES’ IMPLEMENTATION OF AACAP’S BEST PRINCIPLES GUIDELINES
Chapter 2 STATEMENT OF SENATOR SCOTT BROWN. HEARING ON "THE FINANCIAL AND SOCIETAL COSTS OF MEDICATING AMERICA'S FOSTER CHILDREN"
Chapter 3 TESTIMONY OF BRYAN SAMUELS, COMMISSIONER, ADMINISTRATION ON CHILDREN, YOUTH AND FAMILIES, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. HEARING ON "THE FINANCIAL AND SOCIETAL COSTS OF MEDICATING AMERICA'S FOSTER CHILDREN"
Social-emotional, behavioral, and mental health needs of children in child welfare
Psychotropic medication use among children in foster care
Chapter 4 TESTIMONY OF MATT SALO, EXECUTIVE DIRECTOR, NATIONAL ASSOCIATION OF MEDICAID DIRECTORS. HEARING ON "THE FINANCIAL AND SOCIETAL COSTS OF MEDICATING AMERICA'S FOSTER CHILDREN"
PHARMACEUTICAL COVERAGE FOR CHILDREN IN FOSTER CARE
Research on Psychotropic Impacts on Children
Integrated and Coordinated Care
Chapter 5 STATEMENT OF DR. JON MCCLELLAN, PROFESSOR, UNIVERSITY OF WASHINGTON, SEATTLE, WASHINGTON. HEARING ON "THE FINANCIAL AND SOCIETAL COSTS OF MEDICATING AMERICA'S FOSTER CHILDREN"